Tata Chemicals Faces Share Price Drop and Target Cut Amid Weak Q4 Results

[{ "selector": ".ddznl-a", "duration": "500ms", "fill": "forwards", "delay": "0ms", "keyframes": [ {"offset": 0, "transform": "translateX(-376px) scale(0.15)", "opacity": "1"}, {"offset": 1, "transform": "translateX(0) scale(1)", "opacity": "1"} ] }, { "selector": ".paqld-a", "duration": "500ms", "fill": "forwards", "delay": "0ms", "keyframes": [ {"offset": 0, "transform": "translateX(calc(360px - -14px)) scale(0.15)", "opacity": "1"}, {"offset": 1, "transform": "translateX(0px) scale(1)", "opacity": "1"} ] }, { "selector": ".dzdgq-a", "duration": "500ms", "fill": "forwards", "delay": "0ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".xmzwz-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".ddxuu-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".ktwqr-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(-80px)", "opacity": "1"}, {"offset": 1, "transform": "translateX(0)", "opacity": "1"} ] }]

- Tata Chemicals' shares plummeted over 4% as Q4FY24 results show a net loss of ₹841 crore, compared to a profit of ₹692 crore last year.

- Non-cash write-down of assets in the UK contributed to the loss.

[{ "selector": ".greld-a", "duration": "500ms", "fill": "forwards", "delay": "350ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".lpqza-a", "duration": "350ms", "fill": "forwards", "delay": "1100ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".eilqe-a", "duration": "500ms", "fill": "forwards", "delay": "1800ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".jzuqc-a", "duration": "500ms", "fill": "forwards", "delay": "1800ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }]

- Revenue for Q4FY24 declined by 21.1% to ₹3,475 crore from ₹4,407 crore YoY.

- Consolidated EBITDA dropped by 18% QoQ and 54% YoY, missing analyst estimates by 11%.

[{ "selector": ".maeto-a", "duration": "500ms", "fill": "forwards", "delay": "350ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".fwnwt-a", "duration": "350ms", "fill": "forwards", "delay": "1100ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".omzzl-a", "duration": "500ms", "fill": "forwards", "delay": "1800ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".imsin-a", "duration": "500ms", "fill": "forwards", "delay": "1800ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }] Click Here

- Kotak Institutional Equities attributes weak earnings to soda ash pricing pressure globally.

- Earnings likely to remain subdued amid oversupply; large impairment charges in the UK indicate challenges.

[{ "selector": ".zagcz-a", "duration": "500ms", "fill": "forwards", "delay": "350ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".odqjs-a", "duration": "350ms", "fill": "forwards", "delay": "1100ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".qjjwf-a", "duration": "500ms", "fill": "forwards", "delay": "1800ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".gqrnd-a", "duration": "500ms", "fill": "forwards", "delay": "1800ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }]

- Despite earnings collapse, Tata Chemicals stock retains stability amid hopes for Tata Sons IPO, which is unlikely.

- Kotak Equities maintains 'Sell' rating, cuts target price to ₹770 from ₹780, reflecting ongoing challenges.Shares traded 2.06% lower at ₹1,076.40 apiece on the BSE at 10:30 am.

[{ "selector": ".wuufm-a", "duration": "500ms", "fill": "forwards", "delay": "350ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".jscwd-a", "duration": "350ms", "fill": "forwards", "delay": "1100ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".toztl-a", "duration": "500ms", "fill": "forwards", "delay": "1800ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }, { "selector": ".kxmse-a", "duration": "500ms", "fill": "forwards", "delay": "1800ms", "keyframes": [ {"offset": 0, "opacity": 0}, {"offset": 1, "opacity": "1"} ] }]

[{ "selector": ".iglde-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 521px))", "opacity": "40%"}, {"offset": 1, "transform": "translateY(0)", "opacity": "40%"} ] }, { "selector": ".zjuls-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-67px)", "opacity": "41%"}, {"offset": 1, "transform": "translateY(0)", "opacity": "41%"} ] }] Open Demat

Tata Chemicals Faces Share Price Drop and Target Cut Amid Weak Q4 Results

- Tata Chemicals' shares plummeted over 4% as Q4FY24 results show a net loss of ₹841 crore, compared to a profit of ₹692 crore last year.- Non-cash write-down of assets in the UK contributed to the loss.

- Revenue for Q4FY24 declined by 21.1% to ₹3,475 crore from ₹4,407 crore YoY.- Consolidated EBITDA dropped by 18% QoQ and 54% YoY, missing analyst estimates by 11%.

- Kotak Institutional Equities attributes weak earnings to soda ash pricing pressure globally.- Earnings likely to remain subdued amid oversupply; large impairment charges in the UK indicate challenges.

- Tata Chemicals' shares plummeted over 4% as Q4FY24 results show a net loss of ₹841 crore, compared to a profit of ₹692 crore last year.

- Non-cash write-down of assets in the UK contributed to the loss.

- Revenue for Q4FY24 declined by 21.1% to ₹3,475 crore from ₹4,407 crore YoY.

- Consolidated EBITDA dropped by 18% QoQ and 54% YoY, missing analyst estimates by 11%.

- Kotak Institutional Equities attributes weak earnings to soda ash pricing pressure globally.

- Earnings likely to remain subdued amid oversupply; large impairment charges in the UK indicate challenges.